Clinical Trials on HCV Infections

Total 57159 results

Assiut University

Not yet recruiting

Alpha -1- Microglobulin (α1M) as an Early Biomarker in Renal Extrahepatic Manifestations of HCV-infection

HCV | Renal Injury
University of Valencia
Hoffmann-La Roche

Unknown

Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Chronic Hepatitis C | Co-Infection HIV-HCV

Spain
Boston Medical Center

Completed

Anal HPV Infection and Abnormal Cytology in HIV-infected Women

HIV Infections | Cervical Cancer Screening

United States
Dartmouth-Hitchcock Medical Center

Completed

HSV Oral Reactivation in Children

HIV | HSV-1

Tanzania
Institute of HIV Research and Innovation Foundation...

Recruiting

KP-Led Same Day HCV Test and Treat Study (479/65)

HCV, HIV

Thailand
Sinocelltech Ltd.

Recruiting

A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years

HPV Infection Vaccine Safety SCT1000

China
Ulla Bonde van Zwol
University of Southern Denmark; Region of Southern Denmark; MCM Vaccines B.V.

Unknown

Human Papillomavirus and Pregnancy (HPVandPregn)

HPV-infection in Pregnant Women

Denmark
Radboud University Medical Center
Merck Sharp & Dohme LLC

Completed

Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO) (PROMO)

HCV Infections | Gastric Acid-related Disorders

Netherlands
Massachusetts General Hospital
Harvard University

Completed

A Pilot Study of the Grapefruit Flavonoid Naringenin for HCV Infection

Hepatitis C | Hepatitis C Virus | HCV Infection | Chronic HCV

United States
National Institutes of Health Clinical Center (CC)
Washington D.C. Veterans Affairs Medical Center

Completed

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

Hepatitis B | Hepatitis C | HIV-HCV Co-Infection

United States
Hoffmann-La Roche

Terminated

Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)

HIV/HCV Coinfection

Belgium
MagIA Diagnostics

Recruiting

Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C (MAGICIEN)

Combined Point of Care Diagnostic of HIV, HBV and HCV

France
Charles University, Czech Republic
IGA MZ, Czech Republic

Unknown

Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infection

Nonalcoholic Steatohepatitis | Chronic HCV Infection

Czech Republic
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096)

Hepatitis C Virus (HCV) Infection

France
Kirby Institute

Active, not recruiting

Control and Elimination Within Australia of Hepatitis C From People Living With HIV (CEASE)

Hepatitis C | HIV | HIV-HCV Coinfection

Australia
Iveriapharma LLC

Completed

Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex

HSV Infection
University of Roma La Sapienza

Unknown

Infectious Diseases and Movement Program: Study of the Effects of Physical Activity on HIV Infection (PRIMO)

HIV-1-infection

Italy
Capital Medical University

Unknown

The Standard Management of HPV Infection

the High-Risk HPV Infection

China
Erasmus Medical Center

Not yet recruiting

Studying Topiramate for Re-Activating the HIV-1 Reservoir (STAR)

HIV Infections | Hiv | HIV-1-infection | HIV I Infection

Netherlands
PDS Biotechnology Corp.

Completed

An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101

High-risk HPV Infection and Biopsy-proven CIN1

United States
Merck Sharp & Dohme LLC

Completed

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

HPV Infections
Merck Sharp & Dohme LLC

Completed

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

HPV Infections
University of California, Irvine
University of California, Los Angeles; National Institute on Minority Health...

Completed

Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless Adults

Hepatitis C Virus (HCV) Infection

United States
Merck Sharp & Dohme LLC

Completed

V501 Efficacy Study in Women Aged 18 to 26 (V501-027)

HPV Infections
University of Alabama at Birmingham

Completed

A Study to Identify Markers in Blood and Tissue of HPV Clearance

HPV Infections

United States
Merck Sharp & Dohme LLC

Suspended

Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)

HPV Infections
Shanghai Bovax Biotechnology Co., Ltd.

Completed

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

HPV Infections

China
Merck Sharp & Dohme LLC

Completed

V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)

HPV Infections
Yunnan AIDS Care Center

Unknown

Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients

HIV Infections | HBV Coinfection

China
University of North Carolina, Chapel Hill
University of Pretoria; SADC Research Centre

Completed

Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South Africa

HIV Infections | Pregnancy Related | HSV-2 Infection

South Africa
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Long-Term Effects of HIV Exposure and Infection in Children

HIV Infections | HIV Seronegativity

United States, Puerto Rico
University Hospital, Clermont-Ferrand
Merck Sharp & Dohme LLC

Completed

Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis (STREAGER)

Chronic HCV Infection

France
Columbia University
Merck Sharp & Dohme LLC; Jhpiego

Active, not recruiting

HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini

Hiv | HPV Infection | HPV Vaccine

Swaziland
Memorial University of Newfoundland

Recruiting

APPROACH 2.0: HIV, HCV and Syphilis Testing Through Pharmacies

HIV Infections | HCV Infection | Syphilis Infection

Canada
Cancer Institute and Hospital, Chinese Academy...

Unknown

Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)

HIV Infection | HPV Infection | Syphilis

China
Columbia University
National Institute on Drug Abuse (NIDA); University of Miami; Weill Medical College... and other collaborators

Recruiting

Integrated HIV Prevention and HCV Care for PWID (M2HepPrEP)

HIV Prevention | Opioid Use | HCV | Intravenous Drug Usage

Canada, United States
CytoDyn, Inc.

Completed

Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection

HIV Infections | HIV -1 Infection

United States
Northwestern University
Pfizer; Tibotec, Inc

Completed

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 (MIDAS)

HIV Infections | HIV-1 Infection

United States
Centre de Recherches et d'Etude sur la Pathologie...

Completed

Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection. (RADAR)

HIV Infections | HIV-1 Infection

France
Johns Hopkins University

Completed

deLIVER: Direct Acting Antiviral Effects on the Liver (deLIVER)

HIV | Liver Disease | HCV Coinfection

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)

HIV Infections | HIV-1 Infection
Erasmus Medical Center

Recruiting

Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV (EX VIVO)

HIV Infections | HIV-1-infection | HIV-2 Infection

Netherlands
Abdul Latif Jameel Poverty Action Lab
Innovations for Poverty Action

Completed

The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya

HIV/AIDS | HSV-2 Infection
Allegheny Singer Research Institute (also known...

Active, not recruiting

A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA (CAPRI)

HIV Infections | HIV-1-infection | HIV I Infection

United States
Institut de Médecine et d'Epidémiologie Appliquée...

Completed

Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts (DATA)

HIV-1 Infection | Immunosuppression-related Infectious Disease

France
Mohamed Saad

Unknown

Role OF OCT-A TO Detect Possible Retinal Vascular Complications of Sofosbuvir in Patients With Hepatitis C

HCV Infection

Egypt
University of Milan

Unknown

Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults

HIV | HPV

Italy
National Institute for Medical Research, Tanzania

Unknown

Cash Transfer to Adolescent Girls and Young Women to Reduce Sexual Risk Behavior - an Impact Evaluation (CARE)

HIV/AIDS | HSV-2 Infection

Tanzania
Lee's Pharmaceutical Limited

Unknown

Yallaferon in Chinese Population

HPV Infection

China
University of Minnesota

Withdrawn

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

HIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and Infections

United States

Clinical Trials on HCV Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations